COR vs CAH — Key Metrics
| Metric | COR (CENCORA INC) | CAH (CARDINAL HEALTH INC) |
|---|---|---|
| Price | 348.31 | 278.32 |
| Market Cap | 66.47 Billion | 64.33 Billion |
| P/E (TTM) | 25.76 | 35.82 |
| P/B (Quarterly) | 19.841 | -20.464 |
| P/S (TTM) | 0.2 | 0.25 |
| Net Profit Margin (TTM) | 0.8 | 0.7 |
| Gross Margin (TTM) | 4.0 | 3.9 |
| ROE (TTM) | 106.4 | -62.6 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Outperform
Greatly Outperform
Recommendation Summary
Stock COR is projected to outperform the market, stock CAH is projected to greatly outperform the market. Upfront Recommendation: CAH.
Financial Metrics
| COR | Metrics | CAH |
|---|---|---|
| $348.31 | Price | $278.32 |
| — | Market Capitalization | — |
| 25.76 | Price to Earnings Ratio | 35.82 |
| 0.2 | Price to Sales | 0.25 |
| 16.19 | Price to FCF Ratio | 13.0 |
| 5.03 | Price to Gross Profit | 6.4 |
| 1.2 | Price to Current Assets | 1.57 |
COR vs CAH at a glance
Cencora INC (COR) and Cardinal Health INC (CAH) are both Medical Distribution companies in the Healthcare sector. They are similar in size: $66.5 billion and $64.3 billion in market value.
On trailing-twelve-month figures, COR trades at 25.8 times trailing earnings and CAH at 35.8; net profit margins are 0.8% and 0.7%.
The Upfront Investment model currently rates COR Outperform and CAH Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.